Among these were CYR61, which has been shown to be overexpressed and associated with advanced stages of breast cancer [31], and EGR1, which is believed to be a direct regulator of tumor suppressors like TGFB1, TP53 and PTEN [32]. Here, TGFB1 is linked to breast cancer.